Amrubicin shows promise for Small Cell LC

[EastCoastLadi]

I'm sure there are a few of you that already know about this, but I just came across this....

Grace

http://www.cancerpage.com/news/article.asp?id=10464

[teriw]

I didn't know it! Thanks for posting that. Interesting that a lot of the newer drugs are coming from Japan. I guess that's the place to watch.

[melindasue37]

Does anyone know much about this new drug??

[RandyW]

This Drug is in Clinical Trial and Recruiting Eldeerly patients for at least one trial

http://www.clinicaltrials.gov/ct/show/NCT00286169

and this trial

http://www.clinicaltrials.gov/ct/show/NCT00319969

Research Center, Sumitomo Pharmaceuticals Co., Ltd., Osaka.

Amrubicin, a completely synthetic 9-aminoanthracycline derivative, was previously shown to have potent antitumor activities against various human tumor xenografts. In this study, the in vitro activities of amrubicin and its major metabolite, amrubicinol, were examined using 17 human tumor cell lines. Amrubicinol was 5 to 54 times more potent than amrubicin, and as potent as doxorubicin, in inhibiting the growth of the cells following 3-day continuous drug exposure. Amrubicinol closely resembled doxorubicin in its profile of activities on the 17 human tumor cell lines. Cells were incubated with the drugs for 1 h, and the intracellular drug concentration and cell growth inhibition after 3 days were determined. Amrubicinol attained similar intracellular concentrations at lower medium concentrations compared to amrubicin, and the intracellular concentration of amrubicinol necessary to produce 50% cell growth inhibition was 3 to 8 times lower than that of amrubicin in 4 cell lines tested. Amrubicinol has a higher activity level inside the cells than does amrubicin. When cells were incubated with amrubicin for 5 h, a substantial amount of amrubicinol, more than 9% of that of amrubicin, was found in cells in 4 of the 8 cell lines tested. Amrubicinol may contribute to the in vitro growth-inhibitory effect of amrubicin on these cells. The results suggest that amrubicinol plays an important role in the in vivo antitumor effect of amrubicin as an active metabolite.

PMID: 9849587 [PubMed - indexed for MEDLINE]

Hope this helps some